Le Lézard
Classified in: Health, Covid-19 virus
Subjects: CHI, PSF

Thermo Fisher Scientific to Offer Integrated COVID-19 Testing to School Districts Nationwide


WALTHAM, Mass., March 23, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc., the world leader in serving science today announced the launch of a nationwide testing program designed to support U.S. efforts to return to in-person classroom instruction. This program, developed in partnership with Color Health, Inc., a California-based leader in distributed healthcare services, along with leading providers of laboratory testing, aims to support schools as the Biden Administration provides $10 billion in funding to conduct COVID-19 testing. 

The Biden Administration has identified COVID-19 testing in schools as a critical proactive step in the recovery from the pandemic and has proposed a two-pronged strategy that includes both funding for states to administer testing programs and a soon-to-be-awarded federal hub and spoke based program to expand capacity for schools and underserved populations. 

Since the start of the pandemic, Thermo Fisher has supported governments and laboratory partners with COVID-19 testing ramp-up, including equipping a network of labs with capacity to deliver accurate PCR-based individual and pooled testing. Testing programs for this initiative can include PCR-based testing as well as rapid antigen, depending on the school and/or district.

Thermo Fisher's partnership with Color draws on Color's experience serving school districts, major employers, universities, and public health departments to provide critical testing programs. Color's scaled easy-to-use school testing model will provide both convenient sample collection and a seamless result-reporting platform.

"The $10 billion allocation is a critical first step to returning students to school in April, and what happens next is even more critical ? helping schools take advantage," said Mark Stevenson, executive vice president and chief operating officer of Thermo Fisher Scientific. "This program is possible because our industry has already established a strong testing infrastructure during the pandemic and now it's time to make that available where it's needed most urgently."

According to Othman Laraki, chief executive officer of Color, "As we have seen throughout the COVID-19 pandemic, one of the most daunting obstacles has been the ability to effectively address the logistical and accessibility challenges for the last mile of healthcare. This initiative allows us to link individuals in need of COVID-19 tests with available lab capacity near their school or home."

For more information on setting up a testing program for your school district, visit www.thermofisher.com/safeschools or email [email protected].

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.

(PRNewsfoto/Thermo Fisher Scientific)

Media Contact Information:
Ron O'Brien
Phone: 781-622-1242
E-mail: [email protected]

SOURCE Thermo Fisher Scientific


These press releases may also interest you

at 05:15
The "Flow Cytometry Markets. Forecasts by Technology, Product and Application. With Executive and Consultant Guides. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. The technology is moving faster than the market. Find the...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 05:00
Medical equipment manufacturing company Aohua Endoscopy clinched the Endoscopy Product Innovation Award at the recently held Healthcare Asia Medtech Awards 2024 for its development of the Aohua 4K AQ-300 video endoscopy system, which offers an...

at 03:52
The progressive decrease in hearing in elderly people can represent a major problem for their quality of life: it has in fact been demonstrated that critical issues such as these, in addition to being a problem as such, can...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...



News published on and distributed by: